Skip to main content
bioMérieux Worldwide
Discover all our locations
Asia
China (Website)
India (Website)
Indonesia (website)
Japan (Website)
Korea
Malaysia (website)
Philippines (website)
Singapore (Website)
Thailand (website)
Vietnam (website)
Europe, Middle East, Africa
Algeria
Austria (Website)
Belgium
Czech Republic (Website)
Denmark (Website)
Finland (Website)
France (Website)
Germany (Website)
Greece
Hungary
Italy (Website)
Ivory Coast
Netherlands
Norway (Website)
Poland (Website)
Portugal (Website)
Russia (Website)
Serbia
South Africa (Website)
Spain (Website)
Sweden (Website)
Switzerland (Website)
Turkey (Website)
United Arab Emirates
United Kingdom (Website)
North America
Canada (Website)
United States (Website)
Oceania
Australia (Website)
New Zealand (Website)
South America
Argentina (Website)
Brazil (Website)
Chile (Website)
Colombia (Website)
Mexico (Website)
Our Specific Websites
Antimicrobial Resistance Website
bioMérieux Clinical Diagnostics
bioMérieux Industry
bioMérieux Investor Relations
bioMérieux Recruitment
First Line Biology
bioMérieux Corporate
bioMérieux Culture Media
Labguard
Our communities
mybiomerieux.com
myvidas.com
en
fr
Search form
Search
Main menu
Our company
Our mission
Facts & Figures
Our Strategy
Corporate Governance/ Management Committee
bioMérieux Worldwide
Our History
Institut Mérieux
bioMérieux Investor Relations
Corporate Responsibility
Responsibility to society
Responsibility to our workforce
Responsibility to the environment
Ethics & Compliance
Sustainable and socially inclusive purchasing
Global Compact
Internal Audit & Risks
FONDATION MÉRIEUX
OUR EMPLOYEE'S SUCCESS
Expertise
The importance of diagnostics
Clinical diagnostics
Industrial Microbiological Control
Clinical applications
Infectious diseases
Antimicrobial resistance and Healthcare-associated infections
Cardiovascular Emergencies
Personalized medicine
Industrial applications
Agri-food sector
Biopharma & cosmetics sectors
Our technologies, systems and services
Microbiology
Molecular Biology
Immunoassays
Laboratory efficiency
Scientific publications
Clinical Microbiology
Immunoassays
Molecular Biology
Industrial Microbiology
Glossary of Scientific Terms
Innovation
Our innovation strategy
Our vision of innovation
Research & Development
R&D Publications
Careers
Sharing our vision
Career Opportunities
Learning, development and growth
Well-being at work
Embracing Diversity and Inclusion
SHARING OUR VISION
JOB PROFILES
News & Media
Press Releases
Events
Media Center
About bioMérieux
bioMérieux – Fourth-Quarter 2017 Business Review
PRESS CONTACTS
Product Solutions
Clinical Solutions
Industry Solutions
Product Quality & Safety
Customer Service
Technical Library
CLINICAL SOLUTIONS
INDUSTRY SOLUTIONS
Pioneering diagnostics
You are here
Home
News & Media
News & Media
Press Releases
bioMérieux
Events
Media Center
Annual Report
Media library
Press Contacts
About bioMérieux
New logotype and brand identity
News & Media
Press Releases
19 April, 2018
First-Quarter 2018 Business Review
19 April, 2018
bioMérieux submits for FDA Clearance of the BIOFIRE® FILMARRAY® Pneumonia Panel
05 April, 2018
bioMérieux reinforces its offering of High Medical Value immunoassay biomarkers with the acquisition of Astute Medical
28 February, 2018
bioMérieux - 2017 Financial Results
23 January, 2018
bioMérieux – Fourth-Quarter 2017 Business Review
15 January, 2018
CNES and bioMérieux extend their collaboration on Aquapad, a unique water quality testing tool
15 December, 2017
Alexandre Mérieux appointed Chairman and CEO of bioMérieux
18 October, 2017
bioMérieux – Business review for the nine months ended September 30, 2017
30 August, 2017
bioMérieux – First-Half 2017 Results
31 July, 2017
bioMérieux receives FDA clearance for expanded pathogen identification capability on VITEK® MS
27 July, 2017
Sysmex and bioMérieux Agreed to Dissolve the Joint Venture Sysmex bioMérieux Co., Ltd.
Media Contacts
media@biomerieux.com
-
more information
Annual Report 2016 - MP block
View our annual report